Concepedia

Ann Mullally

AM

Statistics

Publications

46

Citations

6.9K

H-Index

34

Active since

2009

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Broad Institute

Memorial Sloan Kettering Cancer Center

Ann Mullally is an author at Brigham and Women's Hospital specializing in life sciences, myeloproliferative neoplasms, and medicine.

ORCID

Publications per year

2009–2022

46

Publications

46

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Omar Abdel‐Wahab, Ann Mullally, Cyrus V. Hedvat et al. · Blood · 2009 · 718 citations · Full text

, , +14

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

Ofir Wolach, Rob S. Sellar, Kimberly Martinod et al. · Science Translational Medicine · 2018 · 454 citations

, , +17

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Ayalew Tefferi, Animesh Pardanani, Omar Abdel‐Wahab et al. · Leukemia · 2009 · 418 citations · Full text

, , +4

Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells

Shilpee Dutt, Anupama Narla, Katherine I. Lin et al. · Blood · 2010 · 403 citations · Full text

, , +12

Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells

Ann Mullally, Steven Lane, Brian Ball et al. · Cancer Cell · 2010 · 392 citations · Full text

, , +17

1–5 of 46